相似文献
1
Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community.
J Neurol Sci. 2020 Dec 15;419:117179. doi: 10.1016/j.jns.2020.117179. Epub 2020 Oct 13.
2
The COVID-19 pandemic, an environmental neurology perspective.
Rev Neurol (Paris). 2022 Jun;178(6):499-511. doi: 10.1016/j.neurol.2022.02.455. Epub 2022 Mar 22.
3
COVID-19 and Neurology: An Emerging Association.
Infect Disord Drug Targets. 2021;21(8):e160921191570. doi: 10.2174/1871526521666210218202226.
4
A plea for equitable global access to COVID-19 diagnostics, vaccination and therapy: The NeuroCOVID-19 Task Force of the European Academy of Neurology.
Eur J Neurol. 2021 Nov;28(11):3849-3855. doi: 10.1111/ene.14741. Epub 2021 Feb 5.
5
Post-COVID-19 neurologic syndrome: Another legacy of the pandemic.
JAAPA. 2022 Sep 1;35(9):19-24. doi: 10.1097/01.JAA.0000854524.40560.f3.
6
A comparative overview of COVID-19, MERS and SARS: Review article.
Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.
7
Beyond Fever, Cough and Dyspnea: The Neurology of COVID-19.
J Assoc Physicians India. 2020 Sep;68(9):62-66.
8
Experiencing COVID19 pandemic and neurology: learning by the recent reports and by old literary or scientific descriptions.
Neurol Sci. 2020 Jun;41(6):1323-1327. doi: 10.1007/s10072-020-04471-w.
9
The emergence of Covid-19: evolution from endemic to pandemic.
J Immunoassay Immunochem. 2022 Jan 2;43(1):22-32. doi: 10.1080/15321819.2021.1991947. Epub 2021 Oct 21.
10
Current Perspective of COVID-19 on Neurology: A Mechanistic Insight.
Comb Chem High Throughput Screen. 2022;25(5):763-767. doi: 10.2174/1386207324666210805121828.
引用本文的文献
1
Post-acute sequelae SARS-CoV-2 infection and neuropathic pain: a narrative review of the literature and future directions.
Pain Manag. 2025 Jun;15(6):333-343. doi: 10.1080/17581869.2025.2501521. Epub 2025 May 14.
2
Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status?
J Headache Pain. 2025 Jan 10;26(1):7. doi: 10.1186/s10194-024-01929-6.
3
Serial Systemic Immune-Inflammation Indices (SSIIi) as Prognostic Markers in Persistent Hypoxic Brain Injury Post-cardiac Arrest: A Case Report.
Cureus. 2024 Aug 20;16(8):e67299. doi: 10.7759/cureus.67299. eCollection 2024 Aug.
4
Long-COVID autonomic syndrome in working age and work ability impairment.
Sci Rep. 2024 May 23;14(1):11835. doi: 10.1038/s41598-024-61455-y.
5
Definition and measurement of post-COVID-19 conditions in real-world practice: a global systematic literature review.
BMJ Open. 2024 Jan 17;14(1):e077886. doi: 10.1136/bmjopen-2023-077886.
6
SARS-CoV-2 Spike Protein Intensifies Cerebrovascular Complications in Diabetic hACE2 Mice through RAAS and TLR Signaling Activation.
Int J Mol Sci. 2023 Nov 16;24(22):16394. doi: 10.3390/ijms242216394.
7
Sustained CREB phosphorylation by lipid-peptide liquid crystalline nanoassemblies.
Commun Chem. 2023 Nov 6;6(1):241. doi: 10.1038/s42004-023-01043-9.
8
Persistent Cognitive Dysfunction in a Non-Hospitalized COVID-19 Long-Hauler Patient Responding to Cognitive Rehabilitation and Citicoline Treatment.
Brain Sci. 2023 Sep 1;13(9):1275. doi: 10.3390/brainsci13091275.
9
Pharmacological Proposal Approach to Managing Chronic Pain Associated with COVID-19.
Biomedicines. 2023 Jun 24;11(7):1812. doi: 10.3390/biomedicines11071812.
10
Secondary headaches - red and green flags and their significance for diagnostics.
eNeurologicalSci. 2023 Jun 30;32:100473. doi: 10.1016/j.ensci.2023.100473. eCollection 2023 Sep.
本文引用的文献
1
Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
ERJ Open Res. 2020 Oct 26;6(4). doi: 10.1183/23120541.00542-2020. eCollection 2020 Oct.
2
Acute Ischemic Stroke in COVID-19: A Case-Based Systematic Review.
Front Neurol. 2020 Sep 25;11:1031. doi: 10.3389/fneur.2020.01031. eCollection 2020.
3
First Australian Case of Good Recovery of a COVID-19 Patient With Severe Neurological Symptoms Post Prolonged Hospitalization.
Cureus. 2020 Sep 10;12(9):e10366. doi: 10.7759/cureus.10366.
4
Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports.
J Neuroinflammation. 2020 Aug 6;17(1):231. doi: 10.1186/s12974-020-01896-0.
5
Preceding infection and risk of stroke: An old concept revived by the COVID-19 pandemic.
Int J Stroke. 2020 Oct;15(7):722-732. doi: 10.1177/1747493020943815. Epub 2020 Jul 24.
6
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease.
Alzheimers Res Ther. 2020 Jun 4;12(1):69. doi: 10.1186/s13195-020-00640-3.
7
A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):466. doi: 10.1186/s13063-020-04436-6.
8
Clinical Features and Outcomes of 98 Patients Hospitalized with SARS-CoV-2 Infection in Daegu, South Korea: A Brief Descriptive Study.
Yonsei Med J. 2020 May;61(5):431-437. doi: 10.3349/ymj.2020.61.5.431.
9
Impact of SARS-CoV-2 infection on neurodegenerative and neuropsychiatric diseases: a delayed pandemic?
Neurologia (Engl Ed). 2020 May;35(4):245-251. doi: 10.1016/j.nrl.2020.04.002. Epub 2020 Apr 17.
10
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection.
Eur J Intern Med. 2020 Jun;76:14-20. doi: 10.1016/j.ejim.2020.04.037. Epub 2020 Apr 20.
Zotero 插件